Build with KISHO Sign In Sign Up

Kisho

BridgeBio Pharma, Inc. — Rare Disease Pipeline | Kisho | Kisho

BridgeBio Pharma, Inc.

Other

2

Orphan Designations

1

FDA Approvals

11

Rare Diseases

0

News Articles

Disease	Drug(s)	Designation	Approved
ATTRV30M amyloidosis	Attruby	Orphan Designation	-
arrhythmogenic cardiomyopathy with wooly hair and keratoderma	Attruby	Orphan Designation	-
familial amyloid neuropathy	Attruby	Orphan Designation	-
histiocytoid cardiomyopathy	Attruby	Orphan Designation	-
intellectual disability, autosomal dominant 15	Attruby	Orphan Designation	-
malignant carotid body paraganglioma	Encaleret sulfate	Orphan Designation	-
microcephaly-cardiomyopathy syndrome	Attruby	Orphan Designation	-
myofibrillar myopathy 2	Attruby	Orphan Designation	-
penoscrotal transposition	Attruby	Orphan Designation	-
post-treatment Lyme disease syndrome	Encaleret sulfate	Orphan Designation	-
treatment-refractory schizophrenia	Encaleret sulfate	Orphan Designation	-

← Back to Companies